Rhythm Pharmaceuticals (RYTM) Enterprise Value (2017 - 2026)
Rhythm Pharmaceuticals' Enterprise Value was $6.28 billion in Q3 2026, down 0.6% from $6.32 billion a year earlier and down 14.1% from the prior quarter.
Rhythm Pharmaceuticals (RYTM) Enterprise Value (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Rhythm Pharmaceuticals' Enterprise Value was $5.22 billion through Sep 30, 2026, down 17.4% year-over-year; for FY2025, it came in at $6.8 billion, up 114.5% from FY2024.
- Enterprise Value has now increased for four consecutive years, with a five-year compound annual growth rate of 42.9% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $3.17 billion in FY2024 (+29.2%), $2.46 billion in FY2023 (+86.7%), $1.32 billion in FY2022 (+535.5%) and $206.98 million in FY2021 (-81.9%).
- Quarterly Enterprise Value has moved between -$26.21 million (Q2 2022) and $7.31 billion (Q2 2026) over five years.
- Compared with a year earlier, Enterprise Value was higher in seven of the last eight quarters, with growth averaging 66.8%.
- The best year-over-year quarter for Enterprise Value over five years was Q4 2022 (growth of 535.5%); the worst was Q4 2021 (a decline of 81.9%).
- Per Business Quant data, RYTM's Enterprise Value in the three quarters before Q3 2026 was $7.31 billion (Q2 2026), $5.61 billion (Q1 2026) and $6.8 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Rhythm Pharmaceuticals | 7.86 Bn | 6.48 Bn | 79.96 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.28 Bn |
| Jun 30, 2026 | 7.31 Bn |
| Mar 31, 2026 | 5.61 Bn |
| Dec 31, 2025 | 6.80 Bn |
| Sep 30, 2025 | 6.32 Bn |
| Jun 30, 2025 | 3.75 Bn |
| Mar 31, 2025 | 3.05 Bn |
| Dec 31, 2024 | 3.17 Bn |
| Sep 30, 2024 | 2.92 Bn |
| Jun 30, 2024 | 2.19 Bn |
| Mar 31, 2024 | 2.44 Bn |
| Dec 31, 2023 | 2.46 Bn |
| Sep 30, 2023 | 1.06 Bn |
| Jun 30, 2023 | 684.61 Mn |
| Mar 31, 2023 | 719.66 Mn |
| Dec 31, 2022 | 1.32 Bn |
| Sep 30, 2022 | 1.02 Bn |
| Jun 30, 2022 | -26.21 Mn |
| Mar 31, 2022 | 339.57 Mn |
| Dec 31, 2021 | 206.98 Mn |
Rhythm Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=RYTM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "RYTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=RYTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();